Director, Health Economics and Outcomes Research (HEOR)

The Role:

Immunovant is seeking a Director of Health Economics and Outcomes Research (HEOR) who is responsible for developing and implementing global HEOR strategies for Immunovant’s assets across various indications. The responsibilities include all phases of outcomes research, design and implementation of retrospective database studies, assessment of patient reported outcomes, epidemiological studies and economic modeling. This position will sit within the Global Medical Affairs function, and report to the Head of HEOR.

Key Responsibilities: 

• Manage HEOR strategy and related evidence needs for designated assets and/or indications
• Perform HEOR analyses including systematic reviews, RWE, PRO assessments, economic modeling, and other technical projects with expertise - to support U.S. and global payer assessments, disease management guidelines, and formulary evaluations
• Generate evidence to document burden of disease, unmet need, patient reported outcomes (PRO), and health economic aspects related to the value of drug therapy to support pricing and reimbursement
• Collaborate with Commercial team members, to ensure payer positioning and messages align with outcome-based evidence
• Collaborate with other Medical Affairs, Regulatory and Clinical Development colleagues across the organization
• Manage HEOR vendors (e.g., data analysis and model development) for supporting the launch and sustainment of HEOR projects
• Identify and develop relationships with HEOR thought leaders/investigators within assigned therapeutic area responsibilities to facilitate health outcomes, RWE, health economic modeling and other partnerships with Immunovant
• Ensure appropriate compliance in all activities, and follow best practices for HEOR data collection, analysis, modeling, dissemination, and publication
• Develop and participate in publication plans as appropriate, collaborating with internal and external Medical Communications professionals.
• Lead the development of deliverables including AMCP dossiers, global value dossiers, economic models, and other tools to support reimbursement and access requirements
• Coordinate, and validate HEOR related study design, protocols, measurement questionnaires, case report forms, statistical analysis plans, and final reports/publications
• Attend medical/scientific, RWD/RWE and HEOR professional meetings to keep up with changing trends and remain current within the field relating to new research and medical trends affecting each therapeutic area

Requirements:

• PhD or master’s degree in health economics, Outcomes Research, Epidemiology, Public Health, or related discipline
• Strong scientific, health services and outcomes research, and pharmacoeconomics training and experience
• A minimum of five (5) years of prior experience with Health Economics and Outcomes Research within the pharmaceutical or biotechnology industry
• Knowledge of the US healthcare system and its changing needs for health economic and payer analytic information
• Experience in developing economic models and predictive analytics
• Experience in developing GVDs and AMCP dossiers
• Previous experience with global reimbursement such as experience with direct country HTA interactions is preferred
• Experience in Neurology, Endocrinology or Rheumatology rare diseases is preferred
• Strong project management skills with a proven track record of success
• Effective resource/vendor management and delivers results on time and on budget
• Excellent interpersonal, negotiation, influence, and communications skill with the proven ability to communicate effectively across all departments and levels of the organization and translate technical ideas and information for colleagues
• History of successful performance and progressive advancement in relevant professional roles in the pharmaceutical/biotechnology industry, managed care, public sector, academic organization, or HEOR research organization

Work Environment:

• Remote-based
• Dynamic, interactive, fast-paced, and entrepreneurial environment
• Domestic or international travel may be required (up to 30%)